Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Infographic – Record Q3 Global Health Investments

Health care investments Q3 2021

Click on image for full-size view (CB Insights)

30 Oct. 2021. Venture investment volumes in health care and life science start-up companies hit record levels so far in 2021, already surpassing levels for all of 2020. Technology market research company CB Insights highlights these investment trends in its recent report on quarterly global health care funding (registration required).

The CB Insights report covers venture funding for companies in digital health, medical devices, biopharmaceuticals, digital therapeutics, health IT, mental health and wellness technologies, and telehealth worldwide. The $97.8 billion invested in companies developing these technologies so far in 2021 far exceeds the $80.5 billion invested in all of 2020, in about 90 percent of the deals recorded last year. But the 1,904 health care investment deals in just Q3 2021 is also a record, up 15 percent from the previous record of 1,668 deals in the first quarter of 2021.

Venture investments in U.S. health care technology companies totaled $18.3 billion, or 60 percent of the total $30.7 billion invested in this sector in the third quarter, with U.S. companies making up 808 or 42 percent of the transactions. Asian health care technology companies raised $8.6 billion in Q3 in 730 deals, or 38 percent of the total for the quarter. CB Insights says that’s a record percentage for Asian health care venture deals, up 9 points from the third quarter of 2020.

Health care start-ups in Europe raised $2.8 billion in 256 deals during the third quarter, while Canadian companies received some $400 million in 41 deals, and companies in Latin America raised about $100 million in 25 deals. All other regions received some $500 million in 44 transactions.

More from Science & Enterprise:

*     *     *

Comments are closed.